20 May 2022
INHSU is pleased to announce a new hepatitis C education program specifically for pharmacists and representatives from community organisations. This program builds on our existing education program for clinicians and is launching in Alberta, Canada.
People who inject drugs (PWID) represent approximately 90% of newly acquired hepatitis C (HCV) infections. Clinicians working with PWID play an important role in reducing HCV-related morbidity and mortality through early diagnosis and treatment. With the advent of well-tolerated, short-course direct acting antiviral (DAA) HCV regimens with cure rates >95%, there is an opportunity to vastly improve the health outcomes of people living with HCV.
This course is designed for pharmacists and staff at community-based organisations participating in the LiveRx Education Program and other clinical staff working with people who inject drugs. Through self-directed online learning and an interactive online workshop, delivered by local experts, participants will gain the skills to confidently manage hepatitis C in their setting.
Learning objectives:
At the conclusion of this program, participants will be able to:
- Describe the risk factors for HCV infection enabling effective screening and prevention education
- Demonstrate competence conducting and interpreting tests to diagnose HCV
- Recognise risk factors, clinical signs, symptoms and complications of liver disease
- Demonstrate understanding of Direct Acting Antiviral (DAA) therapy for the treatment of HCV and competence in selecting appropriate therapy
- Describe recommended on-treatment monitoring and post-treatment follow up protocols
Register:
The education program will take place online and there are two upcoming dates:
Cost:
The course is free. Places are limited – registration is
essential.
Facilitators:
26th May (flyer):
- Dr Mark Swain, MD, MSc, FRCPC, FAASLD, FCAHS
- Sarah Williams, BSc Pharm, ACPR, Clinical Pharmacist, Hepatology Clinic, Calgary Zone, Alberta Health Services
- Nicola Gale, BSc, BPharm, RPh APA, Clinical Pharmacist, Mint Health + Drugs / Calgary Drop In Centre, CUPS Liver Clinic
11th June (flyer):
- Dr Mark Swain, MD, MSc, FRCPC, FAASLD, FCAHS
- Cal Wenzel Family Foundation Chair in Hepatology, Professor of Medicine, University of Calgary; Hepatologist, Calgary Zone, Alberta Health Services
- Klaudia Zabrzenski, BSc.Pharm, RPh APA, ACE Program Lead, Clinical Pharmacist, Mint Health + Drugs
- Colter Young, BSc. Pharm, RPh, APA, Associate Owner and Pharmacist, Shoppers Drug Mart #3034 | #6029
More information:
For further details please contact education@ashm.org.au
